Recently, these data were confirmed and extended through a genome-wide CRISPR screen demonstrating the importance of endogenous NLRC5 for the expression of BTN3A1–3, and for cancer cells’ recognition and killing by Vγ9Vδ2 T cells (9, 98). This evidence concerns the gene BTN3A1 and cancer.